Target intelligence / Profile preview

Mycobacterial cell envelope integrity modulator (null)

Target
null
Molecular classification
Other, Enzyme, Transporter, Receptor
01

Overview

The mycobacterial cell envelope is a complex, multi-layered structure composed of an outer membrane, peptidoglycan, arabinogalactan, and inner membrane, enriched with unique lipids and glycoproteins such as lipomannan (LM) and lipoarabinomannan (LAM)[3][5]. Integrity and modulation of this envelope are central for the survival of pathogenic mycobacteria, enabling the bacteria to resist many antibiotics and evade host immune responses[3][6]. Recent research has identified molecular targets—such as Rv0164 (MMAR_0407)[2][4], VirR[1], and components involved in LM/LAM biosynthesis[3][5]—whose inhibition or alteration can increase cell envelope permeability and synergize with conventional antibiotics, offering novel therapeutic strategies. However, "Mycobacterial cell envelope integrity/modulation" is not a single molecule, but rather a functional designation for a group of targets and pathways, and future drug discovery efforts focus on individual molecular components within this system.

Other names
Mycobacterial cell wall integrityEnvelope permeability regulatorMycobacterial envelope modulator
02

Mechanism of action

Increased cell envelope permeability leads to enhanced antibiotic intake and susceptibility Modulation of biosynthesis pathways affects robustness of the envelope Synergistic effects when combined with other antibiotics

03

Biological functions

Cell envelope biogenesisCell permeability controlAntibiotic resistance modulationHost-pathogen interactionCell divisionCell shape maintenance
04

Disease associations

InfectionAntibiotic resistanceImmune evasion
05

Safety considerations

Potential for increased toxicity if envelope permeability is too highLoss of host-pathogen selectivity: non-specific damage to host cells if modulation isn't specificEmergence of resistance through compensatory mutation
06

Interacting drugs

Benzothiazole derivatives (e.g., BT-08, BT-37)

1 more in the full profile.

07

Biomarkers

Ethidium bromide uptake (measures envelope permeability in assays)Changes in LM/LAM biosynthesisVesicle release or ultrastructural changes by microscopy

Beyond the preview

Go deeper on Mycobacterial cell envelope integrity modulator (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial cell envelope integrity modulator (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call